EcoDrugPlus

Proteasome 26s Subunit, Atpase 2

Ensembl ID : ENSSARG00000012920
Gene Symbol: PSMC2
1 External references
225 Possible Orthologues:

Proteasome 26s Subunit, Atpase 5

Ensembl ID : ENSSARG00000009897
Gene Symbol: PSMC5
1 External references
228 Possible Orthologues:

Proteasome 26s Subunit, Atpase 6

Ensembl ID : ENSSARG00000002578
Gene Symbol: PSMC6
1 External references
241 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 1

Ensembl ID : ENSSARG00000000745
Gene Symbol: PSMD1
1 External references
210 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 11

Ensembl ID : ENSSARG00000009023
Gene Symbol: PSMD11
1 External references
285 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 12

Ensembl ID : ENSSARG00000004102
Gene Symbol: PSMD12
1 External references
220 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 13

Ensembl ID : ENSSARG00000012681
Gene Symbol: PSMD13
1 External references
220 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSSARG00000009520
Gene Symbol: PSMD14
1 External references
211 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSSARG00000000320
Gene Symbol: PSMD6
1 External references
212 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSSARG00000010999
Gene Symbol: PRMT5
1 External references
198 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSSARG00000007875
Gene Symbol: PRKCH
1 External references
237 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSSARG00000008567
Gene Symbol: PRKD1
1 External references
204 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).